ロード中...
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia
A key target for novel stroke therapy is the regulation of post-ischemic inflammatory mechanisms. Recent evidence emphasizes the role of T lymphocytes of differing subtypes in the evolution is ischemic brain damage. We have recently demonstrated the benefit of myelin antigen-specific immunodulatory...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3181103/ https://ncbi.nlm.nih.gov/pubmed/21961027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-011-0085-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|